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1. Introduction 
The tridimensional structure(s) of the peptidic hor- 
mone [ I] angiotensin II in a given environment can 
be approached by several techniques, most of them 
applied to solutions of the hormone in various solvents 
or to dry amorphous powders. It would be interesting 
to confirm and to extend the informations thus ob- 
Fig. 1. Angiotensinamide II crystals from trifluorocthanol 
(X 8500). 
Fig. 2. Angiotcnsinamidc II trystals from alcalinc methanol 
(X 10,000). 
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Fig, 3. Angiotensinamide II crystals from ethanol (X 8500). 
tained by different techniques such as X-ray or elec- 
tron diffraction. For this purpose angiotensinamide II 
crystals have been prepared. The present note describes 
their preparation and gives preliminary characteristics. 
2. Material and methods 
Angiotensinamide II has been generously provided 
by Dr. Riniker of Ciba-Geigy, Basel. 10 mg of pure 
peptide were dissolved at room temperature in 0.5 ml 
of trifluoroethanol and trimethylphosphate was added 
until appearance of a faint turbidity. The mixture was 
kept alternatively into the ice box and at room tem- 
perature. After a few days white crystals were found. 
These crystals appeared as hexagonal platelets of a 
size from 1 to 5 p (fig. 1). A second approach was 
made with methanol mixed with a small amount of 
dilute sodium hydroxyde. From an angiotensinamide 
II solution in this solvent crystalline platelets were 
also obtained (fig. 2). In pure ethanol, angiotensinamide 
II is slightly soluble only. A saturated solution made 
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Table 1 
X-ray powder diffraction and electron single crystal diffraction 
spacings. 
X-rays 
d,A 
10.20 
5.10 
4.67 
3.66 
3.36 
3.32 
2.93 
2.79 
2.52 
Intensity 
very strong 
very weak 
strong 
weak 
weak 
weak 
weak 
weak 
weak 
Electrons 
d,A t 3% 
6.36 
5.72 
5.20 
4.57 
4.50 
4.02 
3.18 
2.93 
2.73 
2.67 
2.49 
1.96 
at 40” was slowly cooled and left in the ice box for 
two weeks. Crystals were formed. Their shape was dif- 
ferent from that of the other crystals as shown in fig. 3. 
Their size was also larger, from 5 to 15 p. 
Examination of the crystals was carried out with a 
scanning electronic microscope JSM-U-3 from Jeol 
(Japan). The crystals were dried under high vacuum, 
placed on a brass holder and coated with a film of 
carbon and then of gold. The crystalline powder ob- 
tained from alcaline methanol and from trifluoro- 
ethanol was analyzed by X-ray diffraction in the labor- 
atory of Dr. Monteilhet. The crystals were packed in- 
to a quartz capillary. The capillary to film distance was 
125 mm. The camera was of the Guinier type and Cu 
kal radiation was used. The exposure time was 30 hr. 
The Debye-Scherer pattern obtained showed sharp 
lines. The spacings are given in table 1. The size of the 
crystals yet available discouraged single crystal analy- 
sis by X-ray diffraction. However electron diffraction 
is possible and was performed with a Philips electron 
microscope EM 300 operated at 8 kV. Crystals were 
placed on a carbon coated copper grid (distance to 
camera 286 mm) and directly examined. Typical elec- 
tron diffraction patterns are given in fig. 4. 
3. Results 
Figs. l-3 indicated that angiotensinamide II has 
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Fig. 4. Electron diffraction patterns of angiotensinamide II 
crystals obtained from alcaline methanol. 
been obtained in crystalline form. The crystals are 
deliquescent and their edges have been smoothed dur- 
ing their handling and the process of coating. That the 
crystals represented angiotensinamide indeed was 
ascertained by a variety of techniques, circular dichro- 
ism and infrared absorption spectra and by their speci- 
fic biological activity on the whole rate [2]. The crys- 
talline nature of the material obtained was further 
demonstrated by the X-ray and electron diffraction 
patterns. They corresponded to peptidic material as 
expected. The data of the X-ray diffraction pattern 
could be indexed to several crystalline systems. Thus, 
the sharp and intense reflection at 4.67 A might repre- 
sent the plane 100 of an orthogonal system. On the 
other hand the strong reflection at 10.20 A might re- 
present the plane 100 of a hexagonal system. More 
details are expected in the future and especially from 
the electron diffraction patterns which are under in- 
vestigation. Suffice it to say that in the latter, the re- 
flection at 10.20A has not been found. The first sys- 
tem could be best fit by a /3 structure, whereas the sec- 
ond would correspond more nicely to helical struc- 
tures. Comparing the data collected for other peptides 
of known structure with circular dichroism spectra of 
angiotensinamide II solutions in trlfluoroethanol and 
in al&line methanol, as well as with infra-red spectra 
of angiotenslnamide II powders prepared from the 
same solvents, indicated the probable predominance 
of an antiparallel /I conformation. If this comparison 
holds, the orthogonal system for the crystalline hor- 
mone is the most likely. In this case the unit cell pa- 
rameters would be: a = 4.67 A, b = 6.96 A and c = 
10.20 A. 
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